Authors: FOSTER BJ LORUSSO PM POPLIN E ZALUPSKI M VALDIVIESO M WOZNIAK A FLAHERTY L KASUNIC DA EARHART RH BAKER LH

Citation: Bj. Foster et al., PHASE-I TRIAL OF ADOZELESIN USING THE TREATMENT SCHEDULE OF DAILY X 5EVERY 3 WEEKS, Investigational new drugs, 13(4), 1995, pp. 321-326

Authors: FLEMING GF RATAIN MJ OBRIEN SM SCHILSKY RL HOFFMAN PC RICHARDS JM VOGELZANG NJ KASUNIC DA EARHART RH

Citation: Gf. Fleming et al., PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Journal of the National Cancer Institute, 86(5), 1994, pp. 368-372

Authors: SHAMDAS GJ ALBERTS DS MODIANO M WIGGINS C POWER J KASUNIC DA ELFRING GL EARHART RH

Citation: Gj. Shamdas et al., PHASE-I STUDY OF ADOZELESIN (U-73,975) IN PATIENTS WITH SOLID TUMORS, Anti-cancer drugs, 5(1), 1994, pp. 10-14

Authors: WEISS GR BROWN TD KUHN JG VONHOFF DD EARHART RH ADAMS WJ BREWER JE HOSLEY JD KASUNIC DA

Citation: Gr. Weiss et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORALINTRAVENOUS ADMINISTRATION OF MENOGARIL, Investigational new drugs, 11(1), 1993, pp. 17-27